Anaplastic thyroid carcinoma (ATC) is a very rare neoplasm with an aggressive course. The prognosis has not changed in the last decades and the median survival does not exceed six months. Only few patients with incidental limited ATC will be cured. Different therapeutic options have been explored but the results are disappointing. At present, new drugs and new timing for proper treatment are under investigation. In this short review we have summarized these recent developments.
|Number of pages||3|
|Publication status||Published - Sep 2003|
- Anaplastic thyroid carcinoma
- Integrated radiotherapeutic strategies
ASJC Scopus subject areas
- Cancer Research